Myriad Genetics, Inc.MYGNNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-397.40M
↓ 471% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-69.59M
Historical baseline
PeriodValueYoY Change
2025$-397.40M-567.9%
2024$-59.50M+69.9%
2023$-197.40M-133.1%
2022$-84.70M-788.6%
2021$12.30M+110.0%
2020$-123.40M+12.2%
2019$-140.50M-265.3%
2018$85.00M-25.0%
2017$113.30M+17.5%
2016$96.40M-